[1]覃 艺,邓燕艺,赖昌生,等.手足口病患儿体内免疫球蛋白、补体、C反应蛋白及刺激分析CD80、CD86水平的临床意义及其与丙种球蛋白治疗疗效的关系[J].医学信息,2018,31(02):63-66,70.[doi:10.3969/j.issn.1006-1959.2018.02.022]
 Qin Yi,DENG Yan-yi,LAI Chang-sheng,et al.Clinical Significance of Immunoglobulin,Complement,C-reactive Protein and CD80,CD86 in Children with Hand-foot-mouth Disease and their Relationship with Therapeutic Effect of Gamma Globulin[J].Journal of Medical Information,2018,31(02):63-66,70.[doi:10.3969/j.issn.1006-1959.2018.02.022]
点击复制

手足口病患儿体内免疫球蛋白、补体、C反应蛋白及刺激分析CD80、CD86水平的临床意义及其与丙种球蛋白治疗疗效的关系()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
63-66,70
栏目:
论著
出版日期:
2018-01-15

文章信息/Info

Title:
Clinical Significance of Immunoglobulin,Complement,C-reactive Protein and CD80,CD86 in Children with Hand-foot-mouth Disease and their Relationship with Therapeutic Effect of Gamma Globulin
文章编号:
1006-1959(2018)02-0063-05
作者:
覃 艺邓燕艺赖昌生马晓红甘 宁李 霞丘丽莉
玉林市红十字医院儿科,广西 玉林 537000
Author(s):
Qin YiDENG Yan-yiLAI Chang-shengMA Xiao-hongGAN NingLI XiaQIU Li-li
Department of Pediatrics,Yulin Red Cross Hospital,Yulin 537000,Guangxi,China
关键词:
手足口病免疫球蛋白补体C反应蛋白CD80/CD86丙种球蛋白
Keywords:
Key words:Hand-foot-mouth diseaseImmunoglobulinComplementC-reactive proteinCD80/CD86Gamma globulin
分类号:
R725.1
DOI:
10.3969/j.issn.1006-1959.2018.02.022
文献标志码:
A
摘要:
目的 探讨手足口病患儿血清免疫球蛋白、C反应蛋白、补体C3、C4、刺激分子CD80、CD86水平的临床意义,及其与丙种球蛋白治疗疗效的关系。方法 观察对象为我院儿科2015年7月~11月收治的60例重症HFMD患儿及60例非重症HFMD患儿,同时收集30例正常儿童血清样本作为对照组。比较各组患者血清免疫球蛋白、CRP、补体C3、C4、刺激分子CD80、CD86水平的差异与患儿病情严重程度之间的关系。另将重症HFMD患儿分为A、B两个亚组,A组进行常规营养支持对症治疗,B组在A组的治疗基础上联用人丙种免疫球蛋白治疗,比较A、B两组患儿病情的进展情况及与各指标之间的关系。结果 治疗前,重症HFMD患儿血清IgA、IgM、IgG及补体C3、C4显著低于普通组及对照组,差异有统计学意义(P<0.05),同时普通组IgA、IgM、IgG及补体C3显著低于对照组,差异有统计学意义(P<0.05),普通组补体C4与对照组差异无统计学意义(P>0.05);重症HFMD患儿血清CRP水平明显高于普通组及对照组,差异有统计学意义(P<0.05)。重症组患儿外周血CD80/CD86显著高于普通组及对照组,差异有统计学意义(P<0.05),普通组CD80/CD86显著高于对照组,差异有统计学意义(P<0.05)。治疗前,A、B组患儿各指标无统计学差异(P>0.05)。治疗后,A、B两组各指标相比治疗前均有显著性差异,差异有统计学意义(P<0.05)。A、B两组补体C3、C4水平未出现显著差异,差异无统计学意义(P>0.05),A组CRP水平显著高于B组,差异有统计学意义(P<0.05)。A组外周血CD80/CD86显著高于B组,差异有统计学意义(P<0.05)。结论 HFMD患儿血清免疫球蛋白、补体C3及C4水平比相比正常人群显著下调,且随着病情的加重而降低;CRP及CD80/CD86相比正常人群显著上调,且随着病情的加重而升高,提示这些指标与患儿病情进展密切相关。联合应用丙种球蛋白治疗能够在对症支持治疗的基础上加快患儿康复进程。
Abstract:
Abstract:Objective To investigate the clinical significance of serum immunoglobulin,C-reactive protein,complement C3 and C4,stimulatory molecules CD80 and CD86 in children with hand-foot-mouth disease and its relationship with the therapeutic effect of gamma globulin.Methods The subjects were 60 children with severe HFMD and 60 children with non-severe HFMD admitted to our pediatric department from July 2015 to November 2015.Thirty normal children's serum samples were collected as control group.The relationship between serum immunoglobulin,CRP, complement C3 and C4,CD80 and CD86 levels in patients and the severity of illness in children were compared.Another severe HFMD children were divided into A,B two subgroups,Group A was treated with conventional nutritional support symptomatic treatment.Group B was treated with Group A immunoglobulin on the basis of group A treatment.The progress of the disease in group A and group B was compared with that of each index.Results Before treatment,serum IgA,IgM,IgG and complement C3,C4 in children with severe HFMD were significantly lower than those in normal group and control group,The difference was statistically significant(P<0.05).At the same time,the levels of IgA,IgM,IgG and complement C3 in common group were significantly lower than those in control group,The difference was statistically significant(P<0.05),the normal group of complement C4 and the control group was no significant difference(P>0.05);severe HFMD serum CRP levels were significantly higher than the normal group and the control group,the difference was statistically significant(P<0.05).The levels of CD80/CD86 in peripheral blood of children with severe disease were significantly higher than those of control group and normal group(P<0.05),The common group of CD80/CD86 was significantly higher than the control group,the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in each index between A and B groups (P>0.05).After treatment,the indexes of A and B groups showed significant difference compared with before treatment,the difference was statistically significant(P<0.05).A,B two groups of complement C3,C4 levels were not significantly different,the difference was not statistically significant(P>0.05),the CRP level of A group was significantly higher than that of B group,the difference was statistically significant(P<0.05).A group of peripheral blood CD80/CD86 was significantly higher than the B group,the difference was statistically significant(P<0.05).Conclusion Serum immunoglobulin,complement C3 and C4 levels in children with HFMD were significantly lower than those in the normal population,and decreased with the progression of the disease;CRP and CD80/CD86 were significantly up-regulated compared with the normal population,and with the progression of the disease high,suggesting that these indicators are closely related with the progress of children's condition.The combination of gamma globulin therapy can speed up the rehabilitation process in children based on symptomatic and supportive treatment.

参考文献/References:

[1]Wang J,Jing P,Liu L,et al.Clinical and Associated Immunological Manifestations of HFMD Caused by Different Viral Infections in Children[J].Global Pediatric Health,2016,3(6):237-244.
[2]Pathinayake P S,Hsu A C,Wark P A B.Innate Immunity and Immune Evasion by Enterovirus 71[J].Viruses,2015,7(12):6613-6630.
[3]Qui P T,Khanh T H,Trieu H T,et al.Intravenous magnesium sulfate for the management of severe hand,foot,and mouth disease with autonomic nervous system dysregulation in Vietnamese children:study protocol for a randomized controlled trial[J].Trials,2016,17(1):98.
[4]孙广超,杨思达,陶建平,等.重症和危重症手足口病患儿外周血淋巴细胞亚群分析[J].中国循证儿科杂志,2010,5(4):251-255.
[5]徐媛媛.手足口病患儿外周血炎性标志物及体液免疫联合检测的临床意义[J].医学理论与实践,2016,19(11):1420-1422.
[6]陈大宇,覃培栩,郑敏,等.儿童手足口病免疫球蛋白与T淋巴细胞亚群的表达与价值[J].国际检验医学杂志,2014,35(7):928-929.
[7]Corrales-Aguilar E,Trilling M,Reinhard H,et al.Highly individual patterns of virus-immune IgG effector responses in humans[J].Medical Microbiology&Immunology,2016,7(11):1-16.
[8]Kim Y I,Song J H,Kwon B E,et al.Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection[J].Vaccine,2015,33(48):6604-6610.
[9]Wu Y,Chen D,Zhou J,et al.Detection of cerebrospinal fluid anti-enterovirus 71 IgM in children with severe hand,food and mouth disease induced by enterovirus 71 infection and its clinical significance[J].Zhonghua Er Ke Za Zhi Chinese Journal of Pediatrics,2015,53(5):355-359.
[10]Lim P Y,Hickey A C,Jamiluddin M F,et al.Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates[J].Vaccine,2015,33(44):6017-6024.
[11]Taniuchi M,Platts-Mills J A,Begum S,et al.Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants[J].Vaccine,2016,34(27):3068-3075.
[12]Ramirez-Fort M K,Downing C,Doan H Q,et al.Coxsackievirus A6 associated hand,foot and mouth disease in adults: clinical presentation and review of the literature[J].Journal of Clinical Virology the Official Publication of the Pan American Society for Clinical Virology,2014,60(4):381-386. [13]李士桂,付四毛,刘玉玲,等.手足口病患儿早期检测超敏C反应蛋白、肌钙蛋白和心肌酶谱的意义[J].海南医学院学报,2014,20(4):552-554.
[14]Yuan A,Li J,Liu P,et al.Association of interleukin-6-572C/G gene polymorphism and serum or cerebrospinal fluid interleukin-6 level with enterovirus 71 encephalitis in Chinese Han patients with hand,foot,and mouth disease[J].Inflammation,2014,38(2):728-735.
[15]Shi W,Hou X,Peng H,et al.MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells[J].Virology Journal,2014,11(1):1-13.
[16]Ng Q,Fang H,Kwang J.Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines[J].Viruses,2015,7(12):6441-6457.

相似文献/References:

[1]任燕.手足口病患儿血清淋巴细胞免疫分型的水平变化及临床意义[J].医学信息,2018,31(01):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
 REN Yan.Serum Level of Lymphocyte Immunophenotype in Children with Hand-foot-mouth Disease and its Clinical Significance[J].Journal of Medical Information,2018,31(02):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
[2]李 淼,孙浩淼,纵书芳,等.徐州地区2015~2016年手足口病流行病学特征分析[J].医学信息,2018,31(02):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
 LI Miao,SUN Hao-miao,ZONG Shu-fang,et al.Epidemiological Characteristics of Hand-foot-mouth Disease in Xuzhou Area in 2015 to 2016[J].Journal of Medical Information,2018,31(02):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
[3]唐培渊,宋俊峰,秦克乐,等.难治性特发性血小板减少性紫癜的治疗进展[J].医学信息,2018,31(05):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
 TANG Pei-yuan,SONG Jun-feng,QIN Ke-le,et al.Progress in Treatment of Refractory Idiopathic Thrombocytopenic Purpura[J].Journal of Medical Information,2018,31(02):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
[4]覃 艺,邓燕艺,赖昌生,等.554例儿童重症手足口病的临床特征分析[J].医学信息,2018,31(11):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
 QIN Yi,DENG Yan-yi,LAI Chang-sheng,et al.Analysis of Clinical Features of Severe Hand Foot and Mouth Disease in 554 Children[J].Journal of Medical Information,2018,31(02):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
[5]兰文林,白宝鑫,石武祥.手足口病研究进展及防治措施[J].医学信息,2018,31(15):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
 LAN Wen-lin,BAO Bao-xin,SHI Wu-xiang.Research Progress and Control Measures of Hand-Foot-Mouth Disease[J].Journal of Medical Information,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
[6]刘 娜,闫卫利.2016年我院儿童病院肠道病毒71型感染情况调查[J].医学信息,2018,31(15):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
 LIU Na,YAN Wei-li.Investigation of Human Enterovirus 71 Infection in our Children's Hospital in 2016[J].Journal of Medical Information,2018,31(02):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
[7]管 建,姜娟娟.血清IL-6、IL-10、CRP和PCT水平检测对手足口病早期 合并细菌感染患儿的临床诊断价值[J].医学信息,2018,31(15):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
 GUAN Jian,JIANG Juan-juan.Clinical Diagnostic Value of Serum Levels of IL-6,IL-10,CRP and PCT in Children with Hand-Foot-and-Mouth Disease Combined with Early Bacterial Infection[J].Journal of Medical Information,2018,31(02):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
[8]孙 伟.腹腔镜胆囊切除术治疗结石性胆囊炎的临床效果观察[J].医学信息,2019,32(03):113.[doi:10.3969/j.issn.1006-1959.2019.03.035]
 SUN Wei.Clinical Observation of Laparoscopic Cholecystectomy for Calculus Cholecystitis[J].Journal of Medical Information,2019,32(02):113.[doi:10.3969/j.issn.1006-1959.2019.03.035]
[9]李正兰.重组人干扰素α1b治疗小儿手足口病的临床疗效观察[J].医学信息,2019,32(05):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
 LI Zheng-lan.Clinical Observation of Recombinant Human Interferon α1b in the Treatment of Hand-Foot-Mouth Disease in Children[J].Journal of Medical Information,2019,32(02):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
[10]陆志刚,梁 洁,钟 敏.新疆第八师石河子市2015~2018年手足口病原学特征及病流行病学分析[J].医学信息,2019,32(06):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
 LU Zhi-gang,LIANG Jie,ZHONG Min.Epidemiological Characteristics and Epidemiological Analysis of Hand,Foot and Mouth in Shihezi City,the Eighth Division of Xinjiang from 2015 to 2018[J].Journal of Medical Information,2019,32(02):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]

更新日期/Last Update: 2018-02-15